CORDARONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cordarone, and when can generic versions of Cordarone launch?
Cordarone is a drug marketed by Wyeth Pharms Inc and Wyeth Pharms and is included in two NDAs.
The generic ingredient in CORDARONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cordarone
A generic version of CORDARONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
Summary for CORDARONE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 26 |
Patent Applications: | 5,416 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORDARONE at DailyMed |
Recent Clinical Trials for CORDARONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Calgary | Phase 4 |
University Hospital, Caen | Phase 4 |
Our Lady of the Lake Regional Medical Center | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CORDARONE
US Patents and Regulatory Information for CORDARONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | CORDARONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 020377-001 | Aug 3, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms | CORDARONE | amiodarone hydrochloride | TABLET;ORAL | 018972-001 | Dec 24, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |